In the context of globalization, Cooper Pharma focuses part of its strategy on the international market, thus considering export as a vector of development and competitiveness.

Cooper Pharma has adapted its internal organization in order to create and maintain a synergy between its In-licensing and Out-licensing activities. Cooper Pharma, with its regional experience, can make its partners benefit from a broad distribution network deeply rooted in several countries in Sub-Saharan Africa, Maghreb and the Middle East.


Our strategy is based on:

A permanent upgrading of the manufacturing facilities

Adaptation of products and services (marketing and medical support, product portfolio) to foreign markets

Registration of the regulatory file according to both European and local requirements

Commercial responsiveness

Development of our own sales force in several African countries.


In 2013, Cooper Pharma opened a subsidiary called “COOPER INTERNATIONAL”, based in Dubai, in the United Arab Emirates. This new subsidiary supports all export activities of Cooper Pharma in Saudi Arabia, Middle East and Francophone Africa.